UBS Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06M | Sell |
227,865
-635,911
| -74% | -$2.97M | ﹤0.01% | 4317 |
|
2025
Q1 | $4.74M | Sell |
863,776
-870,715
| -50% | -$4.78M | ﹤0.01% | 2999 |
|
2024
Q4 | $5.88M | Buy |
1,734,491
+1,451,239
| +512% | +$4.92M | ﹤0.01% | 2825 |
|
2024
Q3 | $807K | Buy |
283,252
+119,613
| +73% | +$341K | ﹤0.01% | 3752 |
|
2024
Q2 | $368K | Sell |
163,639
-32,974
| -17% | -$74.2K | ﹤0.01% | 4140 |
|
2024
Q1 | $435K | Buy |
196,613
+62,201
| +46% | +$137K | ﹤0.01% | 4199 |
|
2023
Q4 | $316K | Buy |
134,412
+59,972
| +81% | +$141K | ﹤0.01% | 4300 |
|
2023
Q3 | $138K | Buy |
74,440
+71,083
| +2,117% | +$132K | ﹤0.01% | 4519 |
|
2023
Q2 | $8.8K | Sell |
3,357
-44,463
| -93% | -$116K | ﹤0.01% | 6133 |
|
2023
Q1 | $77.9K | Buy |
47,820
+21,707
| +83% | +$35.4K | ﹤0.01% | 5047 |
|
2022
Q4 | $34.7K | Buy |
26,113
+11,065
| +74% | +$14.7K | ﹤0.01% | 5929 |
|
2022
Q3 | $23K | Buy |
15,048
+11,991
| +392% | +$18.3K | ﹤0.01% | 6128 |
|
2022
Q2 | $5K | Sell |
3,057
-47,294
| -94% | -$77.4K | ﹤0.01% | 7905 |
|
2022
Q1 | $129K | Buy |
50,351
+37,719
| +299% | +$96.6K | ﹤0.01% | 4710 |
|
2021
Q4 | $37K | Sell |
12,632
-13,900
| -52% | -$40.7K | ﹤0.01% | 6089 |
|
2021
Q3 | $65K | Buy |
26,532
+20,641
| +350% | +$50.6K | ﹤0.01% | 5035 |
|
2021
Q2 | $24K | Sell |
5,891
-210,940
| -97% | -$859K | ﹤0.01% | 6067 |
|
2021
Q1 | $978K | Buy |
216,831
+204,793
| +1,701% | +$924K | ﹤0.01% | 3377 |
|
2020
Q4 | $59K | Buy |
12,038
+3,959
| +49% | +$19.4K | ﹤0.01% | 5058 |
|
2020
Q3 | $48K | Sell |
8,079
-7,843
| -49% | -$46.6K | ﹤0.01% | 4834 |
|
2020
Q2 | $42K | Sell |
15,922
-13,922
| -47% | -$36.7K | ﹤0.01% | 5176 |
|
2020
Q1 | $58K | Sell |
29,844
-13,769
| -32% | -$26.8K | ﹤0.01% | 4830 |
|
2019
Q4 | $307K | Buy |
43,613
+15,461
| +55% | +$109K | ﹤0.01% | 4288 |
|
2019
Q3 | $277K | Buy |
28,152
+14,050
| +100% | +$138K | ﹤0.01% | 4137 |
|
2019
Q2 | $161K | Buy |
14,102
+4,706
| +50% | +$53.7K | ﹤0.01% | 4238 |
|
2019
Q1 | $94K | Hold |
9,396
| – | – | ﹤0.01% | 4326 |
|
2018
Q4 | $160K | Buy |
9,396
+7,072
| +304% | +$120K | ﹤0.01% | 4276 |
|
2018
Q3 | $41K | Buy |
2,324
+1,858
| +399% | +$32.8K | ﹤0.01% | 5409 |
|
2018
Q2 | $9K | Buy |
+466
| New | +$9K | ﹤0.01% | 6285 |
|